Phibro Animal Health
PAHC
191 hedge funds and large institutions have $864M invested in Phibro Animal Health in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 81 increasing their positions, 46 reducing their positions, and 13 closing their positions.
351% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $253K
138% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 13
76% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 46
10% more funds holding
Funds holding: 174 → 191 (+17)
0.67% more ownership
Funds ownership: 98.96% → 99.62% (+0.67%)
4% less capital invested
Capital invested by funds: $902M → $864M (-$38.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$8.11M |
| 2 |
BlackRock
New York
|
+$8.09M |
| 3 |
Renaissance Technologies
New York
|
+$8M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$5.66M |
| 5 |
JP Morgan Chase
New York
|
+$5.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$22.2M |
| 2 |
FIM
Foresters Investment Management
New York
|
-$18.8M |
| 3 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$10.7M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.94M |
| 5 |
PCM
Polaris Capital Management
Boston,
Massachusetts
|
-$2.42M |
PAHC Hedge Fund Activity: Q3 2018 in Review
191 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2018, worth a combined $864M — down 4.3% from $902M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new PAHC positions and 13 closed out — a net gain of 18 holders — while 81 added to existing stakes and 46 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $8.11M. The largest seller was Copper Rock Capital Partners, exiting entirely with an estimated $22.2M sold.
- 191 institutional investors held Phibro Animal Health (PAHC) as of Q3 2018, up from 174 in Q2 2018.
- Funds reported $864M of Phibro Animal Health stock for Q3 2018, down 4.3% quarter-over-quarter.
- 31 funds opened new Phibro Animal Health positions in Q3 2018 and 13 closed out, a net change of +18 holders.
- The largest Phibro Animal Health buyer in Q3 2018 was Morgan Stanley, an estimated $8.11M added.
- The largest Phibro Animal Health seller in Q3 2018 was Copper Rock Capital Partners, an estimated $22.2M sold.
Based on aggregated 13F filings for Q3 2018.